Pancreatic cancer drug daraxonrasib from Revolution Medicines succeeds in trial
Revolution Medicines‘ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of…
Tag: daraxonrasib
Ben Sasse shines spotlight on daraxonrasib for pancreatic cancer
Revolution Medicines could be on the cusp of a breakthrough. The company expects to soon release results from a Phase…